Snapshot

The Emergency Use Listing (EUL) Procedure for Vaccines pathway has been developed by the of WHO.

This pathway can be used where unlicensed vaccines and therapeutics.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

There are 3 phases of the EUL procedure: (i) Pre-emergency phase; (ii) Emergency phase; and (iii) Post-listing phase. The initial review of a medical product is usually 3 months (1 month if submission received during public health emergency). The recommendation for EUL is usually issued by WHO in 5 working days.